Precipio inc.

Precipio’s IV-Cell ® culturing media is a critical reagent intended to be used by cytogenetics laboratories to simplify, speed up and provide greater accuracy of their hematologic (blood cancer ...Nov 22, 2023 · The Precipio, Inc. stock price fell by -1.21% on the last day (Wednesday, 22nd Nov 2023) from $7.11 to $7.03. During the last trading day the stock fluctuated 4.23% from a day low at $6.86 to a day high of $7.15. The price has fallen in 7 of the last 10 days and is down by -11.3% for this period. Volume fell on the last day along with the stock ... Precipio Technologies Private Limited is a Private incorporated on 21 November 2018. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. …On March 26, 2020, Precipio. Inc. (“we” or the “Company”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”) pursuant to which Lincoln Park has agreed to purchase from us, from time to time, up to …

Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.

Precipio, Inc. (PRPO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 7.00 -0.22 (-3.05%) At close: 03:20PM EST 6.74 +0.01 (+0.15%) After hours: 04:09PM EST Summary Company...

Aug 17, 2023 · Precipio, Inc. (NASDAQ:NASDAQ:PRPO) Q2 2023 Earnings Conference Call August 17, 2023 5:00 PM ETCompany ParticipantsIlan Danieli - CEOConference Call... Aug 20, 2020 · Follow. NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement ... Omnipoint Communications Incorporated used to be a phone service provider that went through various mergers and eventually became T-Mobile. The company name has resurfaced due to scam calls all across the country whose numbers are identifie...Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and ...

A company with a name that ends in “inc.” is incorporated, giving its owners, officers and investors specific legal advantages. Essentially, these key people in the business have no personal liability in the event that the business fails or...

C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below)

Precipio Corporate Deck. Who is Precipio? We are creating clinically impactful, cost-effective cancer diagnostic technologies to eliminate laboratory diagnostic errors. Discover how we excel as a blood cancer laboratory, dedicated to specialized diagnostic services for physicians and patients. Learn more at Precipio. Nov 16, 2023 · Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. Nov 29, 2023 · Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. NEW HAVEN, Conn., Aug. 01, 2023 -- Specialty cancer diagnostics company Precipio, Inc. , announces that Q2-2023 revenues have increased to $3.5M in Q2-2023 from $2.8M in Q1-2023, an increase of 25%...Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell.On May 12, 2020, Precipio, Inc (the "Company") announced that management will host a Q1-2020 Corporate Update Call for Shareholders on Tuesday, May 19th, 2020 at 5:00 PM EST. A copy of the letter is attached hereto as Exhibit …

May 4, 2023 · Precipio, Inc. May 4, 2023 at 10:00 AM · 3 min read. Precipio, Inc. Customer’s revenues expected at $750K at full capacity. NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- Specialty cancer ... Item 8.01. Other Events. On May 23, 2019, Precipio, Inc. (the “Company”) announced that Ilan Danieli, its Chief Executive Officer, adopted a stock trading plan in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), to purchase shares of the Company’s common stock (the “Plan”).About Precipio. Precipio, LLC is a full service management consulting firm that supports clients to achieve their business objectives. Precipio applies proven, client-centric Business and Performance Excellence Strategies and Execution to create Client Value and lasting Business Process Transformation. We apply our broad and deep knowledge of ...Please Note: Precipio Wealth Management is a tradename. All services provided by Precipio Wealth Management investment professionals provided in their individual capacities as investment adviser representatives of Mercer Global Advisors Inc. (“Mercer Advisors”), an SEC-registered investment adviser principally located in Denver, …Nov 30, 2023 · A high-level overview of Precipio, Inc. (PRPO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 4747690069000001043961--12-312021Q3false1757691622708292P7DP10DP1D3000300030003000P5Y0001043961prpo:LincolnParkMember2018-09-072018-09-070001043961prpo ...Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in …

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective. If any of the securities being registePrecipio Inc. PRPO (U.S.: Nasdaq) Overview News Precipio Inc. No significant news for in the past two years. Key Stock Data Shares Sold Short 295,864 Change from Last -9.22% Percent of Float...

Sep 21, 2023 · Precipio, Inc. NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse ... Conference Call to be held on November 20th, 2023 at 5:00 PM ESTNEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be ...PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter . Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)Precipio Corporate Deck. Who is Precipio? We are creating clinically impactful, cost-effective cancer diagnostic technologies to eliminate laboratory diagnostic errors. Discover how we excel as a blood cancer laboratory, dedicated to specialized diagnostic services for physicians and patients. Learn more at Precipio.Precipio, Inc. (NASDAQ:NASDAQ:PRPO) Q2 2023 Earnings Conference Call August 17, 2023 5:00 PM ETCompany ParticipantsIlan Danieli - CEOConference Call...BCREATICK INNOVATIVES PRIVATE LIMITED is a TELANGANA based PRIVATE ltd. Company Registered at dated 27-APR-2023 on Ministry of Corporate Affairs(MCA), The …

Precipio, Inc. Aug 2022 - Present 1 year 4 months Precipio’s Products Division, develops, produces and sells proprietary diagnostic products to laboratories.

On September 7, 2018, Precipio. Inc. (“we” or the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC (“LPC”), pursuant to which we have the right to sell to LPC, and LPC has committed to purchase from us, from time to time, up to $10,000,000 of our common stock, subject to certain …

Precipio, Inc. Street Address 1 Street Address 2; 4 Science Park: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; New Haven: CONNECTICUT: 06511 (203) 787-7888: 3. Related Persons. Last Name First Name Middle Name; Danieli: Ilan: Street Address 1 Street Address 2; c/o Precipio, Inc. 4 Science …NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen ® Anemia Panel as part of its suite ...[relinking] Home Product Place Promotion Price Precipio, Inc. (PRPO) reported a revenue of $3.5 million in the first quarter of 2022. The company's net income for the same period was $-3.2 million. In terms of product, Precipio offers diagnostic products and services for oncology and COVID-19 testing. As of 2022, Precipio's stock price is $3.45 per share. …Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in …C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below)BCREATICK INNOVATIVES PRIVATE LIMITED is a TELANGANA based PRIVATE ltd. Company Registered at dated 27-APR-2023 on Ministry of Corporate Affairs(MCA), The …Sep 21, 2023 · Precipio, Inc. NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse ... PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter . Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)Jun 8, 2023 · NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it has entered into securities purchase agreements with ... Precipio, Inc. (PRPO) CEO Ilan Danieli On Q3 2021 Results - Earnings Call Transcript. SA Transcripts Mon, Nov. 15, 2021.Dear Sirs: Reference is hereby made to the securities purchase agreement (the “Agreement”) with each of you as the Investors (the “Investors”), pursuant to which Precipio, Inc. (the “Company”) agreed to issue up to approximately $3,296,703.30 in 8% Senior Secured Convertible Promissory notes with 100% common stock warrant coverage …Precipio, Inc. (NASDAQ:PRPO) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Precipio, Inc., a healthcare solutions company ...

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScree...A high-level overview of Precipio, Inc. (PRPO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.On April 23, 2020, Precipio, Inc. (the “Company”) entered into a promissory note (the “Promissory Note”) evidencing an unsecured $787,200 loan under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently congressionally-approved Coronavirus Aid, Relief, and ...On November 11, 2020, Precipio, Inc (the "Company") announced that management will host a Q3-2020 Corporate Update Call for Shareholders on Thursday, November 19th, 2020 at 5:00 PM EST. A copy of the letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.Instagram:https://instagram. carmax bankruptciesstocks in the russell 2000new crypto on coinbasewhat quarters are most valuable FORM 8-K. CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 16, 2022 PRECIPIO, INC.26 Aug 2021 ... New Haven, CT, and Fort Myers, FL, August 26, 2021 – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American ... kossotcmkts ptraq Products Division revenues begin to diversify beyond HemeScreen®NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) delivered ...Having jurisdiction under 28 U.S.C. § 1291, this court reverses and remands. I. In October 2016, biotechnical company Transgenomic, Inc. and cancer-diagnostics company Precipio, Inc. ("pre-merger Precipio") agreed to form Precipio, Inc. ("post-merger Precipio"). Transgenomic filed a proxy statement with the Securities and … medical reit US74019L6020. Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on …Aug 20, 2020 · Follow. NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement ... Precipio’s IV-Cell ® culturing media is a critical reagent intended to be used by cytogenetics laboratories to simplify, speed up and provide greater accuracy of their hematologic (blood cancer ...